Theracour Pharma, Inc. Insider Profile
4 Followers
Theracour Pharma, Inc., Ten Percent Owner at NanoViricides, holds 33.32M shares in NanoViricides (Ticker: NNVC). Most recently, Theracour Pharma, Inc. Sold 39,000 shares of NanoViricides on Jan 31, 2013 for an estimated value of $19.50K.
Theracour Pharma, Inc.'s Trading History
| NNVCNanoViricides | Jan 31, 2013 | Ten Percent Owner | Informative Sell | 19.50K | $41.32M | |
NNVC Insider Shares: 33.32M (57.86%) | ||||||
You May Also Like
Theracour Pharma, Inc. insider profile FAQ
What is the percentage of profitable transactions made by Theracour Pharma, Inc.?
The percentage of profitable transactions made by Theracour Pharma, Inc. is 50%.
What is the average return per transaction made by Theracour Pharma, Inc.?
The average return per transaction made by Theracour Pharma, Inc. is -67.90%.
What stocks does Theracour Pharma, Inc. hold?
Theracour Pharma, Inc. holds: NNVC stocks.
What was Theracour Pharma, Inc.’s latest transaction?
Theracour Pharma, Inc.’s latest transaction was an Informative Sell of $19.50K.
What was Theracour Pharma, Inc.'s most profitable transaction?
Theracour Pharma, Inc.’s most profitable transaction was an Informative Sell of NNVC stock on June 25, 2010. The return on the trade was 39.30%.
What is Theracour Pharma, Inc.'s role in NanoViricides?
Theracour Pharma, Inc.'s role in NanoViricides is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
